Addgene: AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer. Skip to main content
Addgene

AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer.

Schneeweis C, Diersch S, Hassan Z, Krauss L, Schneider C, Lucarelli D, Falcomata C, Steiger K, Ollinger R, Kramer OH, Arlt A, Grade M, Schmidt-Supprian M, Hessmann E, Wirth M, Rad R, Reichert M, Saur D, Schneider G
Cell Mol Life Sci. 2022 Dec 19;80(1):12. doi: 10.1007/s00018-022-04638-y. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

Antibodies from Article